Tirzepatide FDA approval date

The FDA approved Tirzepatide (ZEPBOUND) on 13 May 2022.

FDA approval date
13 May 2022

Drug identity checked against registry records

Also recorded as ZEPBOUND

Included trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2022-05-13DayTirzepatideFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA215866", "applicant_as_listed_by_fda": "ELI LILLY AND CO", "brand_names": ["MOUNJARO", "MOUNJARO (AUTOINJECTOR)", "MOUNJARO KWIKPEN"], "active_ingredients": ["TIRZEPATIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20220513", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026